<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7480628\results\search\disease\results.xml">
  <result pre="cardiac involvement AlwaqfiNizar R.nralwaqfi@just.edu.joIbrahimKhalid S.[], grid.37553.370000 0001 0097 5797Princess Muna" exact="Heart" post="Centre, Department of General Surgery, Faculty of Medicine, Jordan"/>
  <result pre="S.[], grid.37553.370000 0001 0097 5797Princess Muna Heart Centre, Department of" exact="General" post="Surgery, Faculty of Medicine, Jordan University of Science and"/>
  <result pre="otherwise stated in a credit line to the data. Abstract" exact="Severe" post="acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infects host cells"/>
  <result pre="stated in a credit line to the data. Abstract Severe" exact="acute" post="respiratory syndrome coronavirus 2 (SARS-CoV-2) infects host cells through"/>
  <result pre="in a credit line to the data. Abstract Severe acute" exact="respiratory" post="syndrome coronavirus 2 (SARS-CoV-2) infects host cells through angiotensin"/>
  <result pre="a credit line to the data. Abstract Severe acute respiratory" exact="syndrome" post="coronavirus 2 (SARS-CoV-2) infects host cells through angiotensin converting"/>
  <result pre="cells through angiotensin converting enzyme 2 receptors, leading to coronavirus" exact="disease" post="(COVID-19)-related pneumonia, and also causing acute cardiac injury and"/>
  <result pre="receptors, leading to coronavirus disease (COVID-19)-related pneumonia, and also causing" exact="acute" post="cardiac injury and chronic damage to the cardiovascular system."/>
  <result pre="disease (COVID-19)-related pneumonia, and also causing acute cardiac injury and" exact="chronic" post="damage to the cardiovascular system. The purpose of this"/>
  <result pre="also causing acute cardiac injury and chronic damage to the" exact="cardiovascular" post="system. The purpose of this review is primarily reviewing"/>
  <result pre="pathogen, clinical features, diagnosis, and treatment with particular attention to" exact="cardiovascular" post="involvement based on the current evidence. COVID-19 remains a"/>
  <result pre="extra-pulmonary manifestations and their prolonged consequences are frequently overlooked. Pre-existing" exact="cardiovascular disease" post="or acute cardiac complications may contribute to adverse early"/>
  <result pre="manifestations and their prolonged consequences are frequently overlooked. Pre-existing cardiovascular" exact="disease" post="or acute cardiac complications may contribute to adverse early"/>
  <result pre="their prolonged consequences are frequently overlooked. Pre-existing cardiovascular disease or" exact="acute" post="cardiac complications may contribute to adverse early clinical outcome."/>
  <result pre="therapies are being evaluated with promising results. Keywords COVID-19 SARS-CoV-2" exact="Cardiac" post="involvement Background In the last two decades the family"/>
  <result pre="China, caused by a new CoV and was named severe" exact="acute" post="respiratory syndrome CoV (SARS-CoV), it infected more than 8000"/>
  <result pre="caused by a new CoV and was named severe acute" exact="respiratory" post="syndrome CoV (SARS-CoV), it infected more than 8000 with"/>
  <result pre="by a new CoV and was named severe acute respiratory" exact="syndrome" post="CoV (SARS-CoV), it infected more than 8000 with a"/>
  <result pre="the Middle East of a novel CoV called Middle East" exact="respiratory" post="syndrome CoV (MERS-CoV), it infected 857 cases with 35%"/>
  <result pre="Middle East of a novel CoV called Middle East respiratory" exact="syndrome" post="CoV (MERS-CoV), it infected 857 cases with 35% mortality"/>
  <result pre="[1â€&quot;3]. In late December 2019, an outbreak of a mysterious" exact="pneumonia" post="happened in a seafood wholesale wet market, the Huanan"/>
  <result pre="was identified as a novel coronavirus, that was named severe" exact="acute" post="respiratory syndrome CoV 2 (SARS-CoV-2) and the disease related"/>
  <result pre="identified as a novel coronavirus, that was named severe acute" exact="respiratory" post="syndrome CoV 2 (SARS-CoV-2) and the disease related to"/>
  <result pre="as a novel coronavirus, that was named severe acute respiratory" exact="syndrome" post="CoV 2 (SARS-CoV-2) and the disease related to it"/>
  <result pre="named severe acute respiratory syndrome CoV 2 (SARS-CoV-2) and the" exact="disease" post="related to it as CoV disease 2019 (COVID-19) by"/>
  <result pre="2 (SARS-CoV-2) and the disease related to it as CoV" exact="disease" post="2019 (COVID-19) by the World Health Organization (WHO). Later,"/>
  <result pre="8]. On march 11, 2020 WHO declared COVID-19 a pandemic" exact="disease" post="and by May 12, 2020 the virus has spread"/>
  <result pre="comprehensive review is few. And although COVID-19 is predominantly a" exact="respiratory" post="disease, some patients develop severe cardiovascular disease [1]. In"/>
  <result pre="COVID-19 is predominantly a respiratory disease, some patients develop severe" exact="cardiovascular disease" post="[1]. In addition, patients with underlying cardiovascular disease might"/>
  <result pre="is predominantly a respiratory disease, some patients develop severe cardiovascular" exact="disease" post="[1]. In addition, patients with underlying cardiovascular disease might"/>
  <result pre="develop severe cardiovascular disease [1]. In addition, patients with underlying" exact="cardiovascular disease" post="might have an increased risk of mortality [1]. The"/>
  <result pre="severe cardiovascular disease [1]. In addition, patients with underlying cardiovascular" exact="disease" post="might have an increased risk of mortality [1]. The"/>
  <result pre="it is likely the SARS-CoV-2 originated in bats, however the" exact="intermediate" post="host between bat reservoir and human is still unclear"/>
  <result pre="to human transmission of COVID-19 virus is either direct through" exact="respiratory" post="droplets or indirect through contact routes by touching objects"/>
  <result pre="be cultured from stool of infected persons, however, to date" exact="disease" post="transmission through the faecal-oral route is unknown [21]. The"/>
  <result pre="the reproductive number (RO) (i.e. patientâ€™s capability to spread the" exact="disease" post="to people in contact) in a range of 2.20â€&quot;3.58"/>
  <result pre="Covid-19 is the high level of SARS-CoV-2 shedding in the" exact="upper" post="respiratory tract, even among asymptomatic patients, which distinguishes it"/>
  <result pre="is the high level of SARS-CoV-2 shedding in the upper" exact="respiratory" post="tract, even among asymptomatic patients, which distinguishes it from"/>
  <result pre="distinguishes it from SARS-CoV, where replication occurs mainly in the" exact="lower" post="respiratory tract [24, 25]. The SARS-CoV-2 can survive on"/>
  <result pre="it from SARS-CoV, where replication occurs mainly in the lower" exact="respiratory" post="tract [24, 25]. The SARS-CoV-2 can survive on different"/>
  <result pre="7â€‰days, depending on surface type [26]. The virus is highly" exact="stable" post="at 4â€‰Â°C, but at a temperature of 70â€‰Â°C, the"/>
  <result pre="of 70â€‰Â°C, the time for virus inactivation is 5â€‰min [26]." exact="Cardiac" post="involvement COVID-19 is an acute disease that primarily targets"/>
  <result pre="virus inactivation is 5â€‰min [26]. Cardiac involvement COVID-19 is an" exact="acute" post="disease that primarily targets the respiratory system. 2019-nCOV uses"/>
  <result pre="inactivation is 5â€‰min [26]. Cardiac involvement COVID-19 is an acute" exact="disease" post="that primarily targets the respiratory system. 2019-nCOV uses its"/>
  <result pre="involvement COVID-19 is an acute disease that primarily targets the" exact="respiratory" post="system. 2019-nCOV uses its S-spike to bind angiotensin converting"/>
  <result pre="to the cell. ACE2 receptor expressed in both type1 and" exact="type 2" post="pneumocytes but also expressed in other types of cells,"/>
  <result pre="endothelial cells [25]. Patients with cardiac risk factors and established" exact="cardiovascular disease" post="(CVD) seem to be at an increased risk to"/>
  <result pre="cells [25]. Patients with cardiac risk factors and established cardiovascular" exact="disease" post="(CVD) seem to be at an increased risk to"/>
  <result pre="at an increased risk to develop COVID-19 with more severe" exact="disease" post="and worse clinical outcomes [27, 28]. A lso acute"/>
  <result pre="severe disease and worse clinical outcomes [27, 28]. A lso" exact="acute" post="cardiac complications caused by infection with the SARS-CoV-2, increases"/>
  <result pre="outcomes [27, 28]. A lso acute cardiac complications caused by" exact="infection" post="with the SARS-CoV-2, increases the difficulty and complexity of"/>
  <result pre="and complexity of patient treatment. Thus recognizing patients with previous" exact="cardiac disease" post="or developed cardiac complications during course of the disease,"/>
  <result pre="complexity of patient treatment. Thus recognizing patients with previous cardiac" exact="disease" post="or developed cardiac complications during course of the disease,"/>
  <result pre="ACE2 can result in changes of ACE2 pathways leading to" exact="acute" post="injury to the lung, heart, and endothelial cells ["/>
  <result pre="injury to the lung, heart, and endothelial cells [ 29]." exact="Severe" post="COVID-19 disease associated elevated levels of proinflammatory cytokines can"/>
  <result pre="the lung, heart, and endothelial cells [ 29]. Severe COVID-19" exact="disease" post="associated elevated levels of proinflammatory cytokines can result in"/>
  <result pre="in injury to multiple organs, including cardiac myocytes [ 29]." exact="Acute" post="plaque rupture as a part of systemic inflammation and"/>
  <result pre="myocytes [ 29]. Acute plaque rupture as a part of" exact="systemic" post="inflammation and catecholamine surge inherent in this disease can"/>
  <result pre="part of systemic inflammation and catecholamine surge inherent in this" exact="disease" post="can lead to increased plaque vulnerability and possible rupture"/>
  <result pre="lead to increased plaque vulnerability and possible rupture leading to" exact="acute" post="coronary syndrome [29]. Myocardial oxygen supply/demand mismatch due to"/>
  <result pre="increased plaque vulnerability and possible rupture leading to acute coronary" exact="syndrome" post="[29]. Myocardial oxygen supply/demand mismatch due to an increased"/>
  <result pre="mismatch due to an increased cardiometabolic demand associated with the" exact="systemic" post="infection, and the resultant hypoxia due to severe pneumonia"/>
  <result pre="cardiometabolic demand associated with the systemic infection, and the resultant" exact="hypoxia" post="due to severe pneumonia or acute respiratory distress syndrome"/>
  <result pre="the systemic infection, and the resultant hypoxia due to severe" exact="pneumonia" post="or acute respiratory distress syndrome leading to inadequate supply,"/>
  <result pre="infection, and the resultant hypoxia due to severe pneumonia or" exact="acute" post="respiratory distress syndrome leading to inadequate supply, thus resulting"/>
  <result pre="and the resultant hypoxia due to severe pneumonia or acute" exact="respiratory" post="distress syndrome leading to inadequate supply, thus resulting in"/>
  <result pre="resultant hypoxia due to severe pneumonia or acute respiratory distress" exact="syndrome" post="leading to inadequate supply, thus resulting in myocardial damage"/>
  <result pre="disturbances can lead to serious arrhythmias especially in patients with" exact="cardiac disease." post="Hypokalemia induced serious arrhythmias is of particular interest because"/>
  <result pre="12.5â€‰days of contact [15, 23, 30]. A higher risk of" exact="infection" post="has been noticed in older patients, male sex, patients"/>
  <result pre="has been noticed in older patients, male sex, patients with" exact="chronic" post="pulmonary, chronic cardiac or chronic kidney disease, and patients"/>
  <result pre="noticed in older patients, male sex, patients with chronic pulmonary," exact="chronic" post="cardiac or chronic kidney disease, and patients with diabetes"/>
  <result pre="older patients, male sex, patients with chronic pulmonary, chronic cardiac" exact="or chronic" post="kidney disease, and patients with diabetes mellitus, hypertension and"/>
  <result pre="patients, male sex, patients with chronic pulmonary, chronic cardiac or" exact="chronic" post="kidney disease, and patients with diabetes mellitus, hypertension and"/>
  <result pre="male sex, patients with chronic pulmonary, chronic cardiac or chronic" exact="kidney disease," post="and patients with diabetes mellitus, hypertension and malignancy [31]."/>
  <result pre="pulmonary, chronic cardiac or chronic kidney disease, and patients with" exact="diabetes mellitus," post="hypertension and malignancy [31]. Patients at any age can"/>
  <result pre="cardiac or chronic kidney disease, and patients with diabetes mellitus," exact="hypertension" post="and malignancy [31]. Patients at any age can contract"/>
  <result pre="hypertension and malignancy [31]. Patients at any age can contract" exact="infection" post="with the SARS-CoV-2 and any system can be involved."/>
  <result pre="or develop symptoms, ranging from the common mild symptoms of" exact="upper respiratory tract infection" post="of fever, dry cough, dyspnea, myalgia, and fatigue to"/>
  <result pre="develop symptoms, ranging from the common mild symptoms of upper" exact="respiratory" post="tract infection of fever, dry cough, dyspnea, myalgia, and"/>
  <result pre="ranging from the common mild symptoms of upper respiratory tract" exact="infection" post="of fever, dry cough, dyspnea, myalgia, and fatigue to"/>
  <result pre="fever, dry cough, dyspnea, myalgia, and fatigue to the severe" exact="respiratory" post="or multi-organ failure. Less common symptoms include anosmia, diarrhea,"/>
  <result pre="diarrhea, abdominal pain, dizziness, headache and confusion, and hemoptysis. Although" exact="pneumonia" post="is present in most SARS-CoV-2 infected patients, few cases"/>
  <result pre="in most SARS-CoV-2 infected patients, few cases complained of pleuritic" exact="chest" post="pain [15, 25, 27, 32]. There are four clinical"/>
  <result pre="patients according to Diagnosis and Treatment Protocol for Novel Coronavirus" exact="Pneumonia" post="(Trial Version 6) that was released by the National"/>
  <result pre="of pneumonia. Those in the moderate group show fever, and" exact="respiratory" post="symptoms, with radiological findings of pneumonia. Severe cases showing"/>
  <result pre="show fever, and respiratory symptoms, with radiological findings of pneumonia." exact="Severe" post="cases showing any of these criteria: respiratory distress (respiratory"/>
  <result pre="findings of pneumonia. Severe cases showing any of these criteria:" exact="respiratory" post="distress (respiratory rateâ€‰â‰¥â€‰30/min), hypoxemia (blood oxygen saturationâ€‰â‰¤â€‰93%), and lung"/>
  <result pre="within 24â€&quot;48â€‰h. Critical cases meeting any of the following criteria:" exact="Respiratory" post="failure and requiring mechanical ventilation, shock, with other organ"/>
  <result pre="that requires intensive care unit (ICU) care [27]. If the" exact="disease" post="progresses, the median duration period from illness onset to"/>
  <result pre="global MR. Evaluation When treating patients with the diagnosis of" exact="acute" post="viral respiratory tract infection many differential diagnoses related to"/>
  <result pre="MR. Evaluation When treating patients with the diagnosis of acute" exact="viral" post="respiratory tract infection many differential diagnoses related to atypical"/>
  <result pre="Evaluation When treating patients with the diagnosis of acute viral" exact="respiratory" post="tract infection many differential diagnoses related to atypical pathogens"/>
  <result pre="treating patients with the diagnosis of acute viral respiratory tract" exact="infection" post="many differential diagnoses related to atypical pathogens and common"/>
  <result pre="acute viral respiratory tract infection many differential diagnoses related to" exact="atypical" post="pathogens and common viral pneumonia should be considered, such"/>
  <result pre="infection many differential diagnoses related to atypical pathogens and common" exact="viral pneumonia" post="should be considered, such as influenza, parainfluenza, adenovirus, respiratory"/>
  <result pre="many differential diagnoses related to atypical pathogens and common viral" exact="pneumonia" post="should be considered, such as influenza, parainfluenza, adenovirus, respiratory"/>
  <result pre="viral pneumonia should be considered, such as influenza, parainfluenza, adenovirus," exact="respiratory" post="syncytial virus infection, etc. [4] Therefore, it is crucial"/>
  <result pre="should be considered, such as influenza, parainfluenza, adenovirus, respiratory syncytial" exact="virus infection," post="etc. [4] Therefore, it is crucial to trace the"/>
  <result pre="Common laboratory findings in patients with COVID-19 include leucopenia, and" exact="lymphopenia" post="[4, 15, 31, 33]. Lymphopenia is a cardinal feature"/>
  <result pre="creatine kinase and prothrombin time, increased lactate dehydrogenase and D-dimer." exact="Inflammatory" post="markers like serum ferritin and C-reactive protein can be"/>
  <result pre="protein can be elevated. Patients with cardiac involvement, troponin and" exact="brain" post="natriuretic peptide can be elevated also [4, 15, 31,"/>
  <result pre="2, IL7, IL10, granulocyte colony-stimulating factor (GCSF), interferon (IP)10, and" exact="tumor" post="necrosis factor (TNF)-Î± are higher in ICU patients than"/>
  <result pre="high mortality rate [34]. Computed tomography (CT) imaging of the" exact="chest" post="in patients with COVID-19 is not specific and may"/>
  <result pre="and mild clinical features unless they are at risk for" exact="disease" post="progression. Imaging is indicated in a patient with COVID-19"/>
  <result pre="Imaging is indicated in a patient with COVID-19 and worsening" exact="respiratory" post="status. In a resource-constrained environment, imaging is indicated for"/>
  <result pre="with moderate-severe clinical features and a high pretest probability of" exact="disease" post="[36]. Transthoracic echocardiography is recommended for inpatients with heart"/>
  <result pre="of disease [36]. Transthoracic echocardiography is recommended for inpatients with" exact="heart" post="failure, arrhythmia, ECG changes, or newly diagnosed cardiomegaly on"/>
  <result pre="inpatients with heart failure, arrhythmia, ECG changes, or newly diagnosed" exact="cardiomegaly" post="on chest x-ray or CT-chest. However, most radiology societies"/>
  <result pre="heart failure, arrhythmia, ECG changes, or newly diagnosed cardiomegaly on" exact="chest" post="x-ray or CT-chest. However, most radiology societies have warned"/>
  <result pre="most radiology societies have warned undue CT/MRI imaging again for" exact="cardiovascular disease" post="purposes as it can lead to unwanted exposure of"/>
  <result pre="radiology societies have warned undue CT/MRI imaging again for cardiovascular" exact="disease" post="purposes as it can lead to unwanted exposure of"/>
  <result pre="staff. Appropriate prudence is thus warranted [35]. Diagnosis Detection of" exact="viral" post="RNA using real-time reverse transcriptase-polymerase chain reaction (rRT-PCR) is"/>
  <result pre="high detection rates in bronchoalveolar lavage fluid, the Center for" exact="Disease" post="Control and Prevention (CDC) in the United States recommends"/>
  <result pre="Prevention (CDC) in the United States recommends collecting only the" exact="upper" post="respiratory nasopharyngeal swab to decrease the risk of aerosol"/>
  <result pre="(CDC) in the United States recommends collecting only the upper" exact="respiratory" post="nasopharyngeal swab to decrease the risk of aerosol droplets"/>
  <result pre="risk of aerosol droplets exposure to healthcare workers [21, 24]." exact="Cardiac" post="complications Myocardial damage caused by infection with the SARS-CoV-2"/>
  <result pre="healthcare workers [21, 24]. Cardiac complications Myocardial damage caused by" exact="infection" post="with the SARS-CoV-2 undoubtedly increases the difficulty and complexity"/>
  <result pre="the difficulty and complexity of patient treatment. The reported common" exact="Cardiac" post="complications of COVID-19 include; new or worsening heart failure"/>
  <result pre="reported common Cardiac complications of COVID-19 include; new or worsening" exact="heart" post="failure (due to cardiomyopathy or right-sided heart failure caused"/>
  <result pre="of COVID-19 include; new or worsening heart failure (due to" exact="cardiomyopathy" post="or right-sided heart failure caused by pulmonary hypertension), myocarditis,"/>
  <result pre="new or worsening heart failure (due to cardiomyopathy or right-sided" exact="heart" post="failure caused by pulmonary hypertension), myocarditis, and arrhythmia. Myocardial"/>
  <result pre="failure (due to cardiomyopathy or right-sided heart failure caused by" exact="pulmonary" post="hypertension), myocarditis, and arrhythmia. Myocardial injury associated with the"/>
  <result pre="serious nature of the myocardial injury in patients with COVID-19." exact="Blood" post="pressure levels were significantly higher in patients treated in"/>
  <result pre="a report of 138 patients with COVID-19 disease, 7.2% had" exact="acute" post="cardiac injury, and 16.7% had arrhythmia [31]. In another"/>
  <result pre="COVID-19 disease, 7.2% had acute cardiac injury, and 16.7% had" exact="arrhythmia" post="[31]. In another cohort of 191 patients with COVID-19,"/>
  <result pre="injury [28]. In a study of 416 patients with COVID-19," exact="Cardiac" post="injury occurred in 19.7% [38]. Thus recognizing patients with"/>
  <result pre="injury occurred in 19.7% [38]. Thus recognizing patients with previous" exact="cardiac disease" post="or developed cardiac complications during course of the disease,"/>
  <result pre="occurred in 19.7% [38]. Thus recognizing patients with previous cardiac" exact="disease" post="or developed cardiac complications during course of the disease,"/>
  <result pre="a specific treatment of the 2019-nCOV. The main strategies are" exact="symptomatic" post="and supportive care, and to minimize complications. Non-steroidal anti-inflammatory"/>
  <result pre="recommendation is to avoid NSAIDs use in patients with COVID-19" exact="disease" post="[39]. Using corticosteroids in patients with COVID-19 can be"/>
  <result pre="be harmful, steroids can cause fluid retention, electrolyte derangement, and" exact="hypertension" post="and in general, because of potential harm, as was"/>
  <result pre="was learned from SARS data that indicated an increase of" exact="viral" post="shedding [40]. However, treatment with methylprednisolone may be beneficial"/>
  <result pre="treatment with methylprednisolone may be beneficial for patients who develop" exact="acute" post="respiratory distress syndrome (ARDS) [41]. New studies are evaluating"/>
  <result pre="with methylprednisolone may be beneficial for patients who develop acute" exact="respiratory" post="distress syndrome (ARDS) [41]. New studies are evaluating potential"/>
  <result pre="may be beneficial for patients who develop acute respiratory distress" exact="syndrome" post="(ARDS) [41]. New studies are evaluating potential abnormal coagulation"/>
  <result pre="a reduction of 28-day mortality in patients with high sepsis-induced" exact="coagulopathy" post="(SIC) score greater than 4, or D-dimer more than"/>
  <result pre="greater than 4, or D-dimer more than 6 fold of" exact="upper" post="limit of normal, prescribed 40â€&quot;60â€‰mg enoxaparin/day or unfractionated heparin"/>
  <result pre="sick patients and death in confirmed cases with COVID-19 disease." exact="Multiple" post="studies have currently been conducted investigating the potential cure"/>
  <result pre="or calcium channel blockers can induce severe bradycardia leading to" exact="cerebral" post="hypoperfusion with syncope [47]. The current recommendation is to"/>
  <result pre="COVID-19 reported no significant effect of the drug on accelerating" exact="viral" post="clearance [50]. Lopinavir/ritonavir are protease inhibitors that are approved"/>
  <result pre="[50]. Lopinavir/ritonavir are protease inhibitors that are approved for HIV-1" exact="infection" post="treatment. Prolongation of PR and QT intervals leading to"/>
  <result pre="apixaban and rivaroxaban through the inhibition of CYP3A4, thereby increasing" exact="bleeding" post="risk [44]. Cao B, et al. conducted a randomized,"/>
  <result pre="et al. conducted a randomized, controlled, open-label trial involving hospitalized" exact="adult" post="patients with confirmed severe COVID-19 disease. Researchers observed no"/>
  <result pre="observed no survival benefit following treatment with lopinavir/ritonavir in hospitalized" exact="adult" post="patients with severe COVID-19 beyond standard care. Future trials"/>
  <result pre="is a monophosphoramidate prodrug of an adenosine analogue that inhibits" exact="viral" post="RNA synthesis with a broad antiviral spectrum including filoviruses,"/>
  <result pre="antiviral spectrum including filoviruses, paramyxoviruses, pneumoviruses, and coronaviruses. There is" exact="limited" post="information on adverse effects. However, hypokalemia is a common"/>
  <result pre="and coronaviruses. There is limited information on adverse effects. However," exact="hypokalemia" post="is a common reported side effect [52] and there"/>
  <result pre="multicenter trial at ten hospitals in Hubei, China, conducted on" exact="adult" post="patients admitted to hospital for severe COVID-19 disease, remdesivir"/>
  <result pre="and global pandemics remain a persistent threat. COVID-19, primarily a" exact="respiratory" post="disease, is a rapidly evolving pandemic with uncertain pathogenesis"/>
  <result pre="extra-pulmonary manifestations and their prolonged consequences are frequently overlooked. Pre-existing" exact="cardiovascular disease" post="or acute cardiac complications may contribute to adverse early"/>
  <result pre="manifestations and their prolonged consequences are frequently overlooked. Pre-existing cardiovascular" exact="disease" post="or acute cardiac complications may contribute to adverse early"/>
  <result pre="their prolonged consequences are frequently overlooked. Pre-existing cardiovascular disease or" exact="acute" post="cardiac complications may contribute to adverse early clinical outcome."/>
  <result pre="supportive therapies are being evaluated with promising results. Abbreviations SARS-CoV" exact="Severe" post="acute respiratory syndrome coronavirus COVID-19 Coronavirus disease-19 RCT Randomized"/>
  <result pre="therapies are being evaluated with promising results. Abbreviations SARS-CoV Severe" exact="acute" post="respiratory syndrome coronavirus COVID-19 Coronavirus disease-19 RCT Randomized controlled"/>
  <result pre="are being evaluated with promising results. Abbreviations SARS-CoV Severe acute" exact="respiratory" post="syndrome coronavirus COVID-19 Coronavirus disease-19 RCT Randomized controlled trials"/>
  <result pre="being evaluated with promising results. Abbreviations SARS-CoV Severe acute respiratory" exact="syndrome" post="coronavirus COVID-19 Coronavirus disease-19 RCT Randomized controlled trials MERS"/>
  <result pre="COVID-19 Coronavirus disease-19 RCT Randomized controlled trials MERS Middle East" exact="respiratory" post="syndrome WHO World Health Organization RO Reproductive number ACE"/>
  <result pre="Coronavirus disease-19 RCT Randomized controlled trials MERS Middle East respiratory" exact="syndrome" post="WHO World Health Organization RO Reproductive number ACE Angiotensin"/>
  <result pre="Organization RO Reproductive number ACE Angiotensin converting enzyme CVD Cardiovascular" exact="disease" post="ICU Intensive care unit MR Mortality rate IL Interleukin"/>
  <result pre="rate IL Interleukin GCSF Granulocyte colony-stimulating factor IP Interferon TNF" exact="Tumor" post="necrosis factor rRT-PCR Reverse transcriptase-polymerase chain reaction NSAIDs Non-steroidal"/>
  <result pre="rRT-PCR Reverse transcriptase-polymerase chain reaction NSAIDs Non-steroidal anti-inflammatory drugs ARDS" exact="Acute respiratory distress syndrome" post="SIC Sepsis-induced coagulopathy Publisherâ€™s Note Springer Nature remains neutral"/>
  <result pre="Reverse transcriptase-polymerase chain reaction NSAIDs Non-steroidal anti-inflammatory drugs ARDS Acute" exact="respiratory" post="distress syndrome SIC Sepsis-induced coagulopathy Publisherâ€™s Note Springer Nature"/>
  <result pre="chain reaction NSAIDs Non-steroidal anti-inflammatory drugs ARDS Acute respiratory distress" exact="syndrome" post="SIC Sepsis-induced coagulopathy Publisherâ€™s Note Springer Nature remains neutral"/>
  <result pre="Non-steroidal anti-inflammatory drugs ARDS Acute respiratory distress syndrome SIC Sepsis-induced" exact="coagulopathy" post="Publisherâ€™s Note Springer Nature remains neutral with regard to"/>
  <result pre="J Med202038276076210.1056/NEJMe200112631978944 2.PeirisJSChuCMChengVCChanKSHungIFPoonLLet al.HKU/UCH SARS study group clinical progression and" exact="viral" post="load in a community outbreak of coronavirus-associated SARS pneumonia:"/>
  <result pre="3.ZakiAMvan BoheemenSBestebroerTMOsterhausADFouchierRAIsolation of a novel coronavirus from a man with" exact="pneumonia" post="in Saudi ArabiaN Engl J Med20123671814182010.1056/NEJMoa121172123075143 4.HuangCWangYLiXet al.Clinical features"/>
  <result pre="2019 novel coronavirus in Wuhan, ChinaLancet202039549750610.1016/S0140-6736(20)30183-531986264 5.World Health Organization Coronavirus" exact="Disease" post="2019 (COVID-19): situation report â€&quot; 113. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200512-covid-19-sitrep-113.pdf?sfvrsn=feac3b6d_2. 6.World Health"/>
  <result pre="â€&quot; 113. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200512-covid-19-sitrep-113.pdf?sfvrsn=feac3b6d_2. 6.World Health Organization Clinical management of severe" exact="acute" post="respiratory infection when Novel coronavirus (nCoV) infection is suspected"/>
  <result pre="113. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200512-covid-19-sitrep-113.pdf?sfvrsn=feac3b6d_2. 6.World Health Organization Clinical management of severe acute" exact="respiratory" post="infection when Novel coronavirus (nCoV) infection is suspected [EB/OL]."/>
  <result pre="https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200512-covid-19-sitrep-113.pdf?sfvrsn=feac3b6d_2. 6.World Health Organization Clinical management of severe acute respiratory" exact="infection" post="when Novel coronavirus (nCoV) infection is suspected [EB/OL]. (2020-01-11)"/>
  <result pre="management of severe acute respiratory infection when Novel coronavirus (nCoV)" exact="infection" post="is suspected [EB/OL]. (2020-01-11) [2020-02-11] https://covid19-evidence.paho.org/handle/20.500.12663/431. 7.ZhuNZhangDWangWet al.A novel"/>
  <result pre="(2020-01-11) [2020-02-11] https://covid19-evidence.paho.org/handle/20.500.12663/431. 7.ZhuNZhangDWangWet al.A novel coronavirus from patients with" exact="pneumonia" post="in China, 2019N Engl J Med202038272773310.1056/NEJMoa200101731978945 8.Feng H, Yu"/>
  <result pre="Engl J Med202038272773310.1056/NEJMoa200101731978945 8.Feng H, Yu D, Weina L. Coronavirus" exact="Disease" post="2019 (COVID-19): what we know? J Med Virol. 2020;"/>
  <result pre="virus origins and receptor binding. Lancet. 2020. 10.1016/S0140-6736(20)30251. 11.ZhouPYangXLWangXGet al.A" exact="pneumonia" post="outbreak associated with a new coronavirus of probable bat"/>
  <result pre="Q, Li Y, Foley BT, Chaillon A. Evolutionary history, potential" exact="intermediate" post="animal host, and cross-species analyses of SARS-CoV-2. J Med"/>
  <result pre="Liao X, Qian S et al. Community transmission of severe" exact="acute" post="respiratory syndrome coronavirus 2, Shenzhen, China, 2020. Emerg Infect"/>
  <result pre="X, Qian S et al. Community transmission of severe acute" exact="respiratory" post="syndrome coronavirus 2, Shenzhen, China, 2020. Emerg Infect Dis."/>
  <result pre="Qian S et al. Community transmission of severe acute respiratory" exact="syndrome" post="coronavirus 2, Shenzhen, China, 2020. Emerg Infect Dis. 2020;"/>
  <result pre="Shenzhen, China, 2020. Emerg Infect Dis. 2020; 10.3201/eid2606.200239. 14.ChanJYuanSKokKet al.A" exact="familial" post="cluster of pneumonia associated with the 2019 novel coronavirus"/>
  <result pre="Emerg Infect Dis. 2020; 10.3201/eid2606.200239. 14.ChanJYuanSKokKet al.A familial cluster of" exact="pneumonia" post="associated with the 2019 novel coronavirus indicating person-to-person transmission:"/>
  <result pre="F, Lapa D, Carletti F, et al. SARS-CoV-2 Isolation from" exact="ocular" post="secretions of a patient with COVID-19 in Italy with"/>
  <result pre="secretions of a patient with COVID-19 in Italy with prolonged" exact="viral" post="RNA detection. Ann Intern Med. 2020; 10.7326/M20-1176. 18.OngSWTanYKChiaPYet al.Air,"/>
  <result pre="al.Air, surface environmental, and personal protective equipment contamination by severe" exact="acute" post="respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patientJAMA20203231610161210.1001/jama.2020.322732129805"/>
  <result pre="surface environmental, and personal protective equipment contamination by severe acute" exact="respiratory" post="syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patientJAMA20203231610161210.1001/jama.2020.322732129805 19.van"/>
  <result pre="environmental, and personal protective equipment contamination by severe acute respiratory" exact="syndrome" post="coronavirus 2 (SARS-CoV-2) from a symptomatic patientJAMA20203231610161210.1001/jama.2020.322732129805 19.van DoremalenNMorrisDBushmakerTet"/>
  <result pre="by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a" exact="symptomatic" post="patientJAMA20203231610161210.1001/jama.2020.322732129805 19.van DoremalenNMorrisDBushmakerTet al.Aerosol and surface stability of SARS-CoV-2"/>
  <result pre="al.Viral shedding patterns of coronavirus in patients with probable severe" exact="acute" post="respiratory syndromeLancet.20043631699170010.1016/S0140-6736(04)16255-715158632 25.Wang W, Tang J, Wei F. Updated"/>
  <result pre="shedding patterns of coronavirus in patients with probable severe acute" exact="respiratory" post="syndromeLancet.20043631699170010.1016/S0140-6736(04)16255-715158632 25.Wang W, Tang J, Wei F. Updated understanding"/>
  <result pre="2020; 10.1016/S2666-5247(20)30003-3. 27.WuZMcGooganJMCharacteristics of and important lessons from the coronavirus" exact="disease" post="2019 (COVID-19) outbreak in China: summary of a report"/>
  <result pre="report of 72 314 cases from the Chinese Center for" exact="Disease" post="Control and PreventionJAMA20203231239124210.1001/jama.2020.264832091533 28.LiBYangJZhaoFet al.Prevalence and impact of cardiovascular"/>
  <result pre="for Disease Control and PreventionJAMA20203231239124210.1001/jama.2020.264832091533 28.LiBYangJZhaoFet al.Prevalence and impact of" exact="cardiovascular" post="metabolic diseases on COVID-19 in ChinaClin Res Cardiol202010953153810.1007/s00392-020-01626-932161990 29.XiongTYRedwoodSPrendergastBChenMCoronaviruses"/>
  <result pre="Disease Control and PreventionJAMA20203231239124210.1001/jama.2020.264832091533 28.LiBYangJZhaoFet al.Prevalence and impact of cardiovascular" exact="metabolic diseases" post="on COVID-19 in ChinaClin Res Cardiol202010953153810.1007/s00392-020-01626-932161990 29.XiongTYRedwoodSPrendergastBChenMCoronaviruses and the"/>
  <result pre="diseases on COVID-19 in ChinaClin Res Cardiol202010953153810.1007/s00392-020-01626-932161990 29.XiongTYRedwoodSPrendergastBChenMCoronaviruses and the" exact="cardiovascular" post="system: acute and long-term implicationsEur Heart J2020411798180010.1093/eurheartj/ehaa23132186331 30.Bai Y,"/>
  <result pre="COVID-19 in ChinaClin Res Cardiol202010953153810.1007/s00392-020-01626-932161990 29.XiongTYRedwoodSPrendergastBChenMCoronaviruses and the cardiovascular system:" exact="acute" post="and long-term implicationsEur Heart J2020411798180010.1093/eurheartj/ehaa23132186331 30.Bai Y, Yao L,"/>
  <result pre="Cardiol202010953153810.1007/s00392-020-01626-932161990 29.XiongTYRedwoodSPrendergastBChenMCoronaviruses and the cardiovascular system: acute and long-term implicationsEur" exact="Heart" post="J2020411798180010.1093/eurheartj/ehaa23132186331 30.Bai Y, Yao L, Wei T, et al."/>
  <result pre="al.Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected" exact="pneumonia" post="in Wuhan, ChinaJAMA20203231061106910.1001/jama.2020.158532031570 32.Zili Z, Ning Z, Yan S,"/>
  <result pre="Chen X, Cai Y, et al. Risk factors associated with" exact="acute" post="respiratory distress syndrome and death in patients with coronavirus"/>
  <result pre="X, Cai Y, et al. Risk factors associated with acute" exact="respiratory" post="distress syndrome and death in patients with coronavirus disease"/>
  <result pre="Y, et al. Risk factors associated with acute respiratory distress" exact="syndrome" post="and death in patients with coronavirus disease 2019 pneumonia"/>
  <result pre="acute respiratory distress syndrome and death in patients with coronavirus" exact="disease" post="2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020."/>
  <result pre="distress syndrome and death in patients with coronavirus disease 2019" exact="pneumonia" post="in Wuhan, China. JAMA Intern Med. 2020. 10.1001/jamainternmed.2020.0994. 34.TangNBaiHChenXGongJLiDSunZAnticoagulant"/>
  <result pre="34.TangNBaiHChenXGongJLiDSunZAnticoagulant treatment is associated with decreased mortality in severe coronavirus" exact="disease" post="2019 patients with coagulopathyJ Thromb Haemost2020181094109910.1111/jth.1481732220112 35.American College of"/>
  <result pre="35.American College of Radiology. ACR recommendations for the use of" exact="chest" post="radiography and computed tomography (CT) for suspected COVID-19 infection."/>
  <result pre="DR, Haramati BL, Kanne JP, et al. The role of" exact="chest" post="imaging in patient management during the COVID-19 pandemic: a"/>
  <result pre="10.1148/radiol.2020201365. 37.ZhouFYuTDuRet al.Clinical course and risk factors for mortality of" exact="adult" post="inpatients with COVID-19 in Wuhan, China: a retrospective cohort"/>
  <result pre="early corticosteroid treatment on plasma SARS-associated coronavirus RNA concentrations in" exact="adult" post="patientsJ Clin Virol2004330430910.1016/j.jcv.2004.07.006 41.Wu C, Chen X, Cai Y,"/>
  <result pre="X, Cai Y, Xia J, et al. Factors associated with" exact="acute" post="respiratory distress syndrome and death in patients with coronavirus"/>
  <result pre="Cai Y, Xia J, et al. Factors associated with acute" exact="respiratory" post="distress syndrome and death in patients with coronavirus disease"/>
  <result pre="Xia J, et al. Factors associated with acute respiratory distress" exact="syndrome" post="and death in patients with coronavirus disease 2019 pneumonia"/>
  <result pre="acute respiratory distress syndrome and death in patients with coronavirus" exact="disease" post="2019 pneumonia in Wuhan. China. JAMA Intern Med. 2020."/>
  <result pre="distress syndrome and death in patients with coronavirus disease 2019" exact="pneumonia" post="in Wuhan. China. JAMA Intern Med. 2020. 10.1001/jamainternmed.2020.0994. 42.Yao"/>
  <result pre="optimized dosing design of hydroxychloroquine for the treatment of severe" exact="acute" post="respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin Infect Dis. 2020:ciaa237"/>
  <result pre="dosing design of hydroxychloroquine for the treatment of severe acute" exact="respiratory" post="syndrome coronavirus 2 (SARS-CoV-2). Clin Infect Dis. 2020:ciaa237 10.1093/cid/ciaa237."/>
  <result pre="design of hydroxychloroquine for the treatment of severe acute respiratory" exact="syndrome" post="coronavirus 2 (SARS-CoV-2). Clin Infect Dis. 2020:ciaa237 10.1093/cid/ciaa237. 43.Gautret"/>
  <result pre="44.ChanJFYaoYYeungMLet al.Treatment with lopinavir/ritonavir or interferon-Î²1b improves outcome of MERS-CoV" exact="infection" post="in a nonhuman primate model of common marmosetJ Infect"/>
  <result pre="Infect Dis20152121904191310.1093/infdis/jiv39226198719 45.MulanguSDoddLEDaveyRTet al.A randomized controlled trial of Ebola virus" exact="disease" post="therapeuticsN Engl J Med20193812293230310.1056/NEJMoa191099331774950 46.ShenCWangZZhaoFet al.Treatment of 5 critically"/>
  <result pre="with convalescent plasmaJAM.20203231582158910.1001/jama.2020.4783 47.PageRLOâ€™BryantCLChengDet al.Drugs that may cause or exacerbate" exact="heart" post="failure: a scientific statement from the American Heart AssociationCirculation.2016134e32e6910.1161/CIR.000000000000042627400984"/>
  <result pre="cause or exacerbate heart failure: a scientific statement from the" exact="American" post="Heart AssociationCirculation.2016134e32e6910.1161/CIR.000000000000042627400984 48.SvanstrÃ¶mHPasternakBHviidAUse of azithromycin and death from cardiovascular"/>
  <result pre="or exacerbate heart failure: a scientific statement from the American" exact="Heart" post="AssociationCirculation.2016134e32e6910.1161/CIR.000000000000042627400984 48.SvanstrÃ¶mHPasternakBHviidAUse of azithromycin and death from cardiovascular causesN"/>
  <result pre="the American Heart AssociationCirculation.2016134e32e6910.1161/CIR.000000000000042627400984 48.SvanstrÃ¶mHPasternakBHviidAUse of azithromycin and death from" exact="cardiovascular" post="causesN Engl J Med20133681704171210.1056/NEJMoa130079923635050 49.XiongTYRedwoodSPrendergastBChenMCoronaviruses and the cardiovascular system:"/>
  <result pre="death from cardiovascular causesN Engl J Med20133681704171210.1056/NEJMoa130079923635050 49.XiongTYRedwoodSPrendergastBChenMCoronaviruses and the" exact="cardiovascular" post="system: acute and long-term implicationsEur Heart J2020191798180010.1093/eurheartj/ehaa231 50.Tang W,"/>
  <result pre="cardiovascular causesN Engl J Med20133681704171210.1056/NEJMoa130079923635050 49.XiongTYRedwoodSPrendergastBChenMCoronaviruses and the cardiovascular system:" exact="acute" post="and long-term implicationsEur Heart J2020191798180010.1093/eurheartj/ehaa231 50.Tang W, Cao Zhu,"/>
  <result pre="Med20133681704171210.1056/NEJMoa130079923635050 49.XiongTYRedwoodSPrendergastBChenMCoronaviruses and the cardiovascular system: acute and long-term implicationsEur" exact="Heart" post="J2020191798180010.1093/eurheartj/ehaa231 50.Tang W, Cao Zhu, Han M, et al."/>
 </snippets>
</snippetsTree>
